Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Omalizumab on Airway Responsiveness to Adenosine in Patients With Poorly Controlled Asthma

NCT00133042 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT00133042
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00133042 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Omalizumab on Airway Responsiveness to Adenosine in Patients With Poorly Controlled Asthma
Lead sponsor
University of Florida
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2004
Completion date
December 31, 2006
Enrollment
16
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma